Mineral Oxide-Mediated Transient Mucosal Signaling as a Framework for Enhanced Nutrient and Peptide Bioavailability: Hormesis, Tight Junction Physiology, and NRF2 Activation

Background: Oral administration remains the preferred delivery route for supplements and bioactive compounds, yet the mucosal barrier restricts systemic exposure of most therapeutic agents to a small fraction of the administered dose. Enzymatic degradation, pH-dependent instability, and limited paracellular transport collectively constrain bioavailability, particularly for hydrophilic nutrients, peptides, and mineral ions. Framework: This paper proposes a three-mechanism framework to explain how a class of surface-active mineral oxide delivery systems may enhance mucosal absorption through established biological pathways. The framework is grounded entirely in peer-reviewed physiology and pharmacology independent of any proprietary formulation data. Mechanisms: The three proposed mechanisms are: (1) a low-dose, transient reactive oxygen species (ROS) pulse that reversibly modulates tight junction proteins, expanding paracellular permeability within a well-characterized physiological range; (2) surface-mediated delivery of mineral oxide species directly to mucosal epithelial cells, bypassing the portal circulation route that limits conventional oral mineral delivery; and (3) activation of the NRF2-KEAP1-ARE pathway in mucosal cells, upregulating endogenous antioxidant defenses through hormetic adaptation. These mechanisms are supported by the established biology of hormesis, tight junction physiology, mineral pharmacology, and redox signaling. Comparison to Existing Approaches: Liposomal encapsulation protects cargo from gastric degradation but achieves typical oral bioavailability of 1 to 15 percent for peptide cargo and faces instability challenges in the gastrointestinal environment. The mineral oxide delivery approach described here modifies the absorption environment itself rather than encapsulating cargo, representing a mechanistically distinct and potentially complementary strategy. Conclusion: This framework offers a biologically plausible, citation-supported basis for enhanced oral and sublingual delivery of nutrients and peptide compounds. Controlled clinical pharmacokinetic studies are needed to confirm these mechanisms and quantify the magnitude of bioavailability enhancement in human subjects.